Next Article in Journal
Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials
Previous Article in Journal
Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression
Previous Article in Special Issue
Repurposing of Drugs Targeting YAP-TEAD Functions
Article Menu

Export Article

Open AccessEditorial
Cancers 2018, 10(10), 383; https://doi.org/10.3390/cancers10100383

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy

Department of Medical Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8519, Japan
Received: 8 October 2018 / Accepted: 10 October 2018 / Published: 12 October 2018
Full-Text   |   PDF [153 KB, uploaded 12 October 2018]
No abstract available View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Hata, Y. Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy. Cancers 2018, 10, 383.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top